| scholarly article | Q13442814 |
| P50 | author | Kian Fan Chung | Q43222898 |
| Douglas Curran-Everett | Q56550187 | ||
| William W Busse | Q57330018 | ||
| Eugene R Bleecker | Q65560413 | ||
| Nizar N Jarjour | Q88330675 | ||
| Sally E Wenzel | Q88703108 | ||
| Raed A Dweik | Q89215473 | ||
| Benjamin Gaston | Q97548008 | ||
| Serpil C. Erzurum | Q99561107 | ||
| W Gerald Teague | Q114398502 | ||
| Suzy A A Comhair | Q114735589 | ||
| Ronald L Sorkness | Q114735592 | ||
| Jeffrey Hammel | Q114735594 | ||
| National Heart, Lung, and Blood Institute's Severe Asthma Research Program | Q114735607 | ||
| Elliot Israel | Q124853372 | ||
| P2093 | author name string | Mario Castro | |
| William J Calhoun | |||
| Wendy Moore | |||
| Stephen Peters | |||
| P2860 | cites work | Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma | Q24675014 |
| Protection from experimental asthma by an endogenous bronchodilator | Q24684787 | ||
| Asthma phenotypes | Q28211375 | ||
| Standardisation of the measurement of lung volumes | Q28269989 | ||
| Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness | Q28376746 | ||
| Standardization of Spirometry, 1994 Update. American Thoracic Society | Q29547574 | ||
| Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide | Q30436056 | ||
| NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response | Q30454236 | ||
| Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program | Q33725032 | ||
| Pathophysiology of severe asthma | Q34102499 | ||
| Increased nitric oxide in exhaled air of asthmatic patients | Q34321842 | ||
| ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 | ||
| Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 | ||
| Acid stress in the pathology of asthma. | Q35752385 | ||
| Nitric oxide in health and disease of the respiratory system | Q35842979 | ||
| Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma | Q36168449 | ||
| Asthma: defining of the persistent adult phenotypes | Q36578781 | ||
| Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma | Q37282803 | ||
| Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism | Q37378058 | ||
| An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice | Q37522916 | ||
| Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society | Q40549979 | ||
| Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis | Q40764411 | ||
| Expired nitric oxide levels during treatment of acute asthma | Q42061224 | ||
| Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients | Q43604746 | ||
| Factors associated with persistent airflow limitation in severe asthma | Q43732321 | ||
| Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone | Q43796653 | ||
| Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. | Q44247874 | ||
| Severe asthma in adults: what are the important questions? | Q44683157 | ||
| Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics | Q44863693 | ||
| "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids | Q44950357 | ||
| Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension | Q45057087 | ||
| Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure | Q45112213 | ||
| Nitrative stress in refractory asthma | Q46834038 | ||
| Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations | Q46968826 | ||
| Exhaled nitric oxide reflects asthma severity and asthma control | Q47295303 | ||
| Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. | Q50776015 | ||
| Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
| Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge. | Q51687176 | ||
| The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma | Q57892223 | ||
| Enhanced Superoxide Production by Alveolar Macrophages and Air-Space Cells, Airway Inflammation, and Alveolar Macrophage Density Changes after Segmental Antigen Bronchoprovocation in Allergic Subjects | Q67485983 | ||
| Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society | Q68060128 | ||
| Changes in total lung capacity during acute spontaneous asthma | Q68850659 | ||
| Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients | Q70839028 | ||
| Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects | Q71078843 | ||
| Nitric Oxide Synthase in Human and Rat Lung: Immunocytochemical and Histochemical Localization | Q72096286 | ||
| The static elastic properties of the lungs in asthma | Q72119618 | ||
| Elastic recoil of the lungs in chronic asthmatic patients before and after therapy | Q72296406 | ||
| Single-breath nitric oxide measurements in asthmatic patients and smokers | Q72663097 | ||
| Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge | Q73251715 | ||
| Exhaled nitric oxide in patients with asthma: association with NOS1 genotype | Q73286233 | ||
| Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society | Q73286389 | ||
| Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response | Q73497859 | ||
| A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma | Q73838291 | ||
| Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma | Q74363392 | ||
| Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma | Q74363456 | ||
| Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma | Q77747395 | ||
| Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal | Q77950187 | ||
| NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma | Q78120709 | ||
| Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both? | Q80541923 | ||
| Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma | Q81350465 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 1033-1041 | |
| P577 | publication date | 2010-02-04 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma | |
| P478 | volume | 181 |
| Q36787683 | A mobile instrumentation platform to distinguish airway disorders. |
| Q92826655 | Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management |
| Q34545186 | Advances in pediatric asthma in 2010: addressing the major issues |
| Q89615163 | Allergic Endotypes and Phenotypes of Asthma |
| Q38796735 | An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly |
| Q35534747 | An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications |
| Q91964998 | Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma |
| Q38695202 | Arginine metabolic endotypes related to asthma severity. |
| Q92890590 | Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
| Q46221607 | Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids |
| Q88632274 | Asthma Over the Age of 65: All's Well That Ends Well |
| Q47169950 | Asthma biomarkers in the age of biologics |
| Q36292443 | Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study |
| Q39192905 | Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy |
| Q45066429 | Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age. |
| Q36991115 | Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects |
| Q35305384 | Biomarker-based asthma phenotypes of corticosteroid response |
| Q26782718 | Biomarkers and severe asthma: a critical appraisal |
| Q28072326 | Biomarkers for the Phenotyping and Monitoring of Asthma in Children |
| Q38892972 | Biomarkers in Severe Asthma |
| Q37270967 | Biomarkers in airway diseases |
| Q30417360 | Biomarkers in asthma: a real hope to better manage asthma |
| Q34384531 | Cardiovascular biomarkers in exhaled breath |
| Q30407742 | Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program |
| Q26771615 | Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma |
| Q26772201 | Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma |
| Q30277842 | Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma |
| Q37630008 | Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients |
| Q28077546 | Development of New Therapies for Severe Asthma |
| Q37138169 | Diagnostic accuracy of the bronchodilator response in children |
| Q37444407 | Early life microbial exposure and fractional exhaled nitric oxide in school-age children: a prospective birth cohort study |
| Q28395218 | Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials |
| Q55261545 | Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma. |
| Q35072967 | Elevated levels of NO are localized to distal airways in asthma |
| Q38261186 | Emerging molecular phenotypes of asthma |
| Q34105404 | Epigenetic regulation: the interface between prenatal and early-life exposure and asthma susceptibility. |
| Q33735605 | Evolving Concepts of Asthma |
| Q37166409 | Exhaled Nitric Oxide Levels Among Adults With Excessive Alcohol Consumption |
| Q35078159 | Exhaled nitric oxide and clinical phenotypes of childhood asthma |
| Q38754980 | Feasibility of multiple breath washout measurements in infants with bronchiolitis: A pilot study |
| Q92652387 | Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome |
| Q45031378 | Frequent exacerbators--a distinct phenotype of severe asthma |
| Q36992623 | Gender Differences in Respiratory Health of School Children Exposed to Rail Yard-Generated Air Pollution: The ENRRICH Study |
| Q46160784 | Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease |
| Q34960273 | Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways |
| Q55283746 | Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007-2012. |
| Q35849789 | Imaging pulmonary inducible nitric oxide synthase expression with PET. |
| Q43743124 | Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity |
| Q51453447 | Inducible nitric oxide synthase expression is increased in the alveolar compartment of asthmatic patients. |
| Q51846310 | Inflammation and infections in asthma. |
| Q33926448 | Longitudinal assessment of high versus low levels of fractional exhaled nitric oxide among children with asthma and atopy |
| Q36828893 | Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study. |
| Q38150455 | Management of severe asthma in childhood--state of the art and novel perspectives |
| Q35815608 | Metabolomic Endotype of Asthma |
| Q39868533 | Mind-body interactions in the regulation of airway inflammation in asthma: A PET study of acute and chronic stress |
| Q64284788 | Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms |
| Q92661616 | Nasal Nitric Oxide in Chronic Rhinosinusitis with or without Nasal Polyps: A Systematic Review with Meta-Analysis |
| Q38181697 | New treatments for severe treatment-resistant asthma: targeting the right patient |
| Q64911278 | Nitric oxide alters hyaluronan deposition by airway smooth muscle cells. |
| Q35910735 | Nitric oxide and asthma severity: towards a better understanding of asthma phenotypes |
| Q36832237 | Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation |
| Q40850150 | Nitric oxide in asthma physiopathology. |
| Q33755995 | Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study |
| Q36765753 | Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients |
| Q50073556 | Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. |
| Q39148802 | Phenotype-Driven Therapeutics in Severe Asthma |
| Q35811718 | Predicting asthma exacerbations in children |
| Q41489890 | Predicting asthma morbidity in children using proposed markers of Th2-type inflammation |
| Q38048331 | Psychosocial factors and behavioral medicine interventions in asthma |
| Q63916459 | Relationships Between Airway Hyperresponsiveness, Inflammation, and Calibre in Asthma |
| Q36437627 | Respiratory Health Risks for Children Living Near a Major Railyard |
| Q36846745 | Role of exhaled nitric oxide as a predictor of atopy |
| Q54414134 | Severe Asthma in Children. |
| Q36471091 | Severe Asthma in Children: Lessons Learned and Future Directions. |
| Q34858558 | Severe Asthma: The Evolution of Patient-directed Management |
| Q35848235 | Severe asthma in childhood: recent advances in phenotyping and pathogenesis |
| Q30422401 | Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program |
| Q36865999 | Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma |
| Q51539024 | Sputum interleukin-13 as a biomarker for the evaluation of asthma control. |
| Q33610976 | The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium |
| Q37155167 | The Clinical and Health Economic Value of Clinical Laboratory Diagnostics |
| Q40116254 | The STOPPA Twin Study Explains the Exhaled Nitric Oxide and Asthma Link by Genetics and Sensitization |
| Q55308357 | The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity. |
| Q38003661 | The investigation of severe asthma to define phenotypes. |
| Q45846048 | The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma |
| Q35219714 | Update in asthma 2010. |
| Q36105881 | Update in asthma 2011. |
| Q38594456 | Update on the current methods for the diagnosis and treatment of severe childhood asthma |
| Q38126882 | Which biomarkers are effective for identifying Th2-driven inflammation in asthma? |
Search more.